Naschitz, J, Dreyfuss, D, Yeshurun, D et al. · Postgraduate medical journal · 2004 · DOI
This study reports on one patient with severe ME/CFS who was treated with midodrine, a medication that helps regulate blood pressure and heart rate control. The patient's symptoms of dysautonomia (problems with the autonomic nervous system that controls automatic body functions) improved with this treatment, and their fatigue also improved. This suggests that treating the autonomic nervous system dysfunction may help some people with ME/CFS feel better.
This study is important because it provides clinical evidence linking dysautonomia to ME/CFS symptoms and suggests that treating the autonomic nervous system may offer therapeutic benefit. For patients experiencing dysautonomic symptoms like orthostatic intolerance or abnormal heart rate responses, this raises the possibility of a treatable underlying mechanism. The work supports the biological basis of ME/CFS and encourages further research into autonomic-targeted interventions.
This single case report does not prove that midodrine is an effective treatment for ME/CFS broadly, nor does it establish that dysautonomia is the primary cause of ME/CFS in all patients. Individual case reports are susceptible to placebo effect, natural disease fluctuation, and reporting bias. Results from one patient cannot be generalized to the broader ME/CFS population without larger, controlled clinical trials.